Clinical and Translational Radiation Oncology · 2019 · 16 citations · 25 references
MedicineOncologyRadiation OncologyChemotherapyMetastasisSurgical OncologyAdjuvant ChemotherapyCancer Survival AnalysisColorectal CancerNeoadjuvant ChemotherapyResponse AssessmentTherapy Response AssessmentBoostingChemotherapy Response AssessmentDisease-free Survival AnalysisDistant Metastasis-free SurvivalOutcome PredictionT2-weighted ImagingTherapy Response EvaluationTumor Regression Assessment
BACKGROUND AND PURPOSE: was tested as a potential biomarker in predicting long-term disease-free survival. MATERIALS AND METHODS: (CONV_model and REGR_model respectively) were assessed and their discriminative power compared. RESULTS: was also the only variable significantly associated to OS (p = 0.01) and LRFS (p = 0.03). CONCLUSION: in treatment personalization: additional confirmation on independent cohorts is warranted.
25
Andrew G. Renehan, Lee Malcomson, Richard Emsley et al. · The Lancet Oncology · 2015 · 799 citations
Claus Rödel, Ullrich Graeven, Rainer Fietkau et al. · The Lancet Oncology · 2015 · 724 citations